UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression

Scientific reports, 2023-05, Vol.13 (1), p.8779-8779, Article 8779

2023

Volltextzugriff (PDF)

Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer

Medicine (Baltimore), 2024-01, Vol.103 (1), p.e36750-e36750

2024

Volltextzugriff (PDF)

Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center

Medicine (Baltimore), 2023-09, Vol.102 (39), p.e35383-e35383

2023

Volltextzugriff (PDF)

Outcomes of the patients with metastatic male breast cancer

Journal of cancer research and therapeutics, 2024-01, Vol.20 (1), p.98-102

2024

Volltextzugriff (PDF)

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Journal of cancer research and therapeutics, 2023-10, Vol.19 (7), p.1945-1949

2023

Volltextzugriff (PDF)

Comparison of bevacizumab plus doublet chemotherapy regimens in patients with metastatic or recurrent ovarian cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17537-e17537

2023

Volltextzugriff (PDF)

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21149-e21149

2021

Volltextzugriff (PDF)

Abstract PS14-25: Outcomes of metastatic male breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS14-25-PS14-25

2021

Volltextzugriff (PDF)

Abstract PS10-44: Termination of trastuzumab-based treatment after complete response in HER2-positive metastatic breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS10-44-PS10-44

2021

Volltextzugriff (PDF)

Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study

Medicine (Baltimore), 2024-02, Vol.103 (8), p.e37213

2024

Volltextzugriff (PDF)

High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing's sarcoma: A single institution experience

Medicine (Baltimore), 2022-12, Vol.101 (49), p.e32213-e32213

2022

Volltextzugriff (PDF)

Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study

Medicine (Baltimore), 2023-02, Vol.102 (5), p.e32866-e32866

2023

Volltextzugriff (PDF)

Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study

Medicine (Baltimore), 2022-11, Vol.101 (45), p.e31726

2022

Volltextzugriff (PDF)

Efficacy of Bevacizumab-Based Terapy in Patient With Metastatic or Recurrent Cervical Cancer: Real Life Data

Selcuk Tip Dergisi, 2024-06

KHANMAMMADOV, NIJAT

2024

Volltextzugriff (PDF)

Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis: A real-world data from Turkey

Journal of cancer research and therapeutics, 2024-01

2024

Volltextzugriff (PDF)

Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (16), p.14833-14841

2023

Volltextzugriff (PDF)

Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience

Journal of cancer research and therapeutics, 2023-01, Vol.19 (2), p.253-258

2023

Volltextzugriff (PDF)

Predictors of the acquisition of T790M mutation in EGFR mutant metastatic lung cancer patients who were treated with EGFR inhibitors

Eurasian Journal of Pulmonology, 2023-01

Dogan, Izzet

2023

Volltextzugriff (PDF)

Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience

Clinical cancer investigation journal, 2022-05, Vol.11 (3), p.25-29

2022

Volltextzugriff (PDF)

Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib

Clinical cancer investigation journal, 2022-07, Vol.11 (4), p.5-9

2022

Volltextzugriff (PDF)

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib

Türk onkoloji dergisi, 2022

doğan, izzet

2022

Volltextzugriff (PDF)

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study

Türk onkoloji dergisi, 2022

paksoy, nail

2022

Volltextzugriff (PDF)

Assessment of serum endocan levels in patients with beta-thalassemia minor

Revista da Associacao Medica Brasileira (1992), 2022-02, Vol.68 (2), p.147-151

2022

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(23)
magazinearticle
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Humans
(10)
Oncology
(8)
Retrospective Studies
(8)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)
Chemotherapy
(5)
Male
(5)
Metastasis
(5)
Observational Study
(5)
Prognosis
(5)
Adult
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Breast Cancer
(3)
Female
(3)
Metastases
(3)
Middle Aged
(3)
Aged
(2)
Aged, 80 And Over
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression

Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer

Efficacy and outcomes of systemic chemotherapy in posttransplant and immunosuppression associated Kaposi sarcoma: Twenty years experience of a tertiary cancer center

Outcomes of the patients with metastatic male breast cancer

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Comparison of bevacizumab plus doublet chemotherapy regimens in patients with metastatic or recurrent ovarian cancer

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Abstract PS14-25: Outcomes of metastatic male breast cancer

Abstract PS10-44: Termination of trastuzumab-based treatment after complete response in HER2-positive metastatic breast cancer

Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study

High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing's sarcoma: A single institution experience

Weekly paclitaxel treatment in the first-line therapy of classic Kaposi sarcoma: A real-life study

Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study

Efficacy of Bevacizumab-Based Terapy in Patient With Metastatic or Recurrent Cervical Cancer: Real Life Data

Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis: A real-world data from Turkey

Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients

Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience

Predictors of the acquisition of T790M mutation in EGFR mutant metastatic lung cancer patients who were treated with EGFR inhibitors

Crizotinib in Metastatic ALK mutant Non-small Cell Lung Cancer Patients: A Single Centre Experience

Outcomes and Prognostic Factors in Patients with EGFR Mutant Metastatic Non-Small Cell Lung Cancer Who Treated with Erlotinib

Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study

Assessment of serum endocan levels in patients with beta-thalassemia minor

Suchergebnisse filtern